Healthcare - Biotechnology - NASDAQ - US
$ 3.1
-15.5 %
$ 28.6 M
Market Cap
-0.49
P/E
Price Target
Average
100.00%
Revenue Forecast
Estimate
--2.78%
EBIT
Estimate
59.06%
Net Income
Estimate
27.09%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SAB Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SABS of $6.2 , with forecasts ranging from a low of $3 to a high of $8 .
SABS Lowest Price Target
Wall Street Target
3 USD
-3.23%
SABS Average Price Target
Wall Street Target
6.2 USD
100.00%
SABS Highest Price Target
Wall Street Target
8 USD
158.06%
REVENUE FORECAST
Revenue Forecast Chart SABS
EBIT FORECAST
EBIT Forecast Chart SABS
NET INCOME FORECAST
Net Income Chart SABS